Palvella Therapeutics Ratios (2013-2026) | PVLA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)
EBT Margin (Quarter)	-659.76%	-683.00%	-221.65%	-67.89%	-351.73%	-4,622.87%		-782.75%	12.73%	-72.31%		-4,784.91%
EBIT Margin (Quarter)	-659.88%	-683.15%	-221.53%	-67.86%	-355.54%	-4,716.28%		-801.19%	10.29%	-75.84%		-3,318.87%
EBITDA Margin (Quarter)	-608.58%	-580.45%	-187.69%	-45.29%	-307.55%	-3,812.79%		-689.82%	21.27%	-70.36%		-5,150.94%
Operating Margin (Quarter)	-659.88%	-683.15%	-221.53%	-67.86%	-355.54%	-4,716.28%		-801.19%	10.29%	-75.84%		-3,318.87%
Net Margin (Quarter)	-659.76%	-683.00%	-221.65%	-67.89%	-351.73%	-4,622.87%		-782.75%	12.73%	-72.31%		-5,150.94%
FCF Margin (Quarter)	1,168.39%	-511.21%	-239.54%	-208.78%	-441.03%	-3,408.53%		-570.45%	-67.10%	-63.16%		-2,079.25%
Efficiency
Assets Average (Quarter)	135.41M	159.61M	158.87M	145.34M	125.71M	106.74M	97.33M	88.87M	84.90M	73.46M	33.46M	18.52M	27.27M	22.79M	54.38M	83.84M	76.59M	70.34M	63.25M	161.66M
Equity Average (Quarter)	42.48M	50.29M	52.30M	52.10M	48.91M			-39.16M	27.98M	35.50M	-21.99M	-75.68M	-78.85M	-84.12M	-12.40M	59.09M	51.68M	43.23M	33.33M	130.15M
Invested Capital (Quarter)	46.72M	53.85M	50.76M	53.45M	44.37M		-93.78M	15.46M	40.50M	30.51M	-74.48M	-76.87M	-80.83M	-87.40M	64.58M	57.55M	49.76M	40.90M	30.18M	232.31M
Asset Utilization Ratio (Quarter)	0.15	0.13	0.15	0.15	0.18	0.18		0.19	0.30	0.51		2.03	1.31	0.69
Leverage & Solvency
Interest Coverage Ratio (Quarter)													-100.28	-23.01	-24.12
Debt to Equity (Quarter)															0.03	0.04	0.04	0.06	0.08
Debt Ratio (Quarter)															0.02	0.02	0.03	0.03	0.04
Equity Ratio (Quarter)	0.30	0.33	0.33	0.39	0.39		-0.98	0.19	0.46	0.51	-9.87	-2.61	-3.23	-4.26	0.71	0.70	0.65	0.58	0.47	0.88
Times Interest Earned (Quarter)													-100.28	-23.01	-24.12
Valuation
Enterprise Value (Quarter)	-91.80M	-34.90M	-117.76M	-100.27M	-80.94M	-69.82M	-59.17M	-48.38M	-64.84M	-56.72M	-16.32M	-6.25M	-14.54M	-14.21M	-83.60M	-75.63M	-70.43M	-63.57M	-57.98M	-261.85M
Return Ratios
Return on Sales (Quarter)	-0.07%	-0.07%	-0.02%	-0.01%	-0.04%	-0.46%		-0.08%	0.00%	-0.01%		-0.48%	0.00%	0.00%
Return on Capital Employed (Quarter)	-51.63%	-48.44%	-47.85%	-51.23%	-55.23%	-58.67%		-103.19%	-75.09%	-83.92%	-38.16%	17.13%	-14.76%	19.73%	-33.29%	-27.00%	-39.64%	-52.75%	-16.88%	-10.32%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%			0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Palvella Therapeutics Ratios (2013-2026) | PVLA

Create an account

Sign In

Reset Password